Biological Health Risks and Economic Development
With populations aging and the epidemic of obesity spreading across the globe, global health risks are shifting toward non-communicable diseases. Innovative biomarker data from recently conducted population-representative surveys in lower, middle and higher income countries are used to describe how four key biological health risks – hypertension, cholesterol, glucose and inflammation – vary with economic development and, within each country, with age, gender and education. As obesity rises in lower income countries, the burden of non-communicable diseases will rise in roughly predictable ways and the costs to society are potentially very large. Investigations that explain cross-country differences in these relationships will have a major impact on advancing understanding of the complex interplay between biology, health and development.
-
-
Copy CitationElizabeth Frankenberg, Jessica Y. Ho, and Duncan Thomas, "Biological Health Risks and Economic Development," NBER Working Paper 21277 (2015), https://doi.org/10.3386/w21277.
Published Versions
"Biological health risks and economic development." in John Komlos and Inas Rashad Kelly (eds.) The Oxford Handbook of Economics and Human Biology, Oxford University Press, 2016